ETV6 and neoplasm: Other potential tumour suppressive effects include stabilising the expression of YAP and facilitating downregulation of programmed death ligand 1 (PD-L1) on tumour cells [111], and in maintaining cell stemness in AML by regulating expression of ETV6 target genes [112].